24th Sep 2020 14:37
RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - Net asset value per share at June 30 of USD1.34, up from USD1.27 at December 31, 2019. Loss for the first half ended June 30 widens to USD2.2 million from USD29,725 million a year prior. Management fees were biggest expense at USD1.2 million, up from nothing the year before. Believes there is a significant demand for reliable capital providers, such as itself, to continue to support scientific innovation and development of transformative therapies for patients. Intends to grow the company's portfolio, keeping to a 80%-20% split, where 80% is invested in biopharmaceutical assets and 20% across medical technology assets. To further explore opportunities in China.
Current stock price: USD1.54
Year-to-date change: up 12%
By Greg Roxburgh; gregroxburgh@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech